[1]
|
Hebra, F. and Kaposi, M. (1874) On diseases of the skin including exanthemata. New Sydenham Society, 61, 252-258.
|
[2]
|
Cleaver, J.E. (1968) Defective repair replication of DNA in xeroderma pigmentosum. Nature, 218, 652-656. http://dx.doi.org/10.1038/218652a0
|
[3]
|
Kraemer, K.H. (2008) In: Pagon, R.A., Bird, T.C., Dolan, C.R. and Stephens, K., Eds., Xeroderma Pigmentosum, University of Washington, Seattle.
|
[4]
|
Kleijer, W.J., Laugel, V. and Berneburg, M., et al. (2008) Incidence of DNA repair deficiency disorders in western Europe: Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. DNA Repair (Amst), 7, 744-750. http://dx.doi.org/10.1016/j.dnarep.2008.01.014
|
[5]
|
Hirai, Y., Kodama, Y., Moriwaki, S., et al. (2006) Heterozygous individuals bearing a founder mutation in the XPA DNA repair gene comprise nearly 1% of the Japanese population. Mutation Research, 601, 171-178. http://dx.doi.org/10.1016/j.mrfmmm.2006.06.010
|
[6]
|
Reese, A.B. and Wilber, I.E. (1943) The eye manifestations of xeroderma pigmentosum. American Journal of Ophthalmology, 26, 901-911.
|
[7]
|
O’Malley, P.F. and Allen, R.A. (1967) Peripheral cystoid degeneration of the retina. Incidence and distribution in 1000 autopsy eyes. Archives of Ophthalmology, 77, 769-776. http://dx.doi.org/10.1001/archopht.1967.00980020771010
|
[8]
|
Pearce, W.G. (1972) Ocular and genetic features of Cockayne’s syndrome. Canadian Journal of Ophthalmology, 7, 435-444.
|
[9]
|
Dollfus, H., Porto, F., Caussade, P., et al. (2003) Ocular manifestations in the inherited DNA repair disorders. Survey of Ophthalmology, 48, 107-122. http://dx.doi.org/10.1016/S0039-6257(02)00400-9
|
[10]
|
Brumback, R.A., Yoder, F.W., Andrews, A.D., et al. (1978) Normal pressure hydrocephalus. Recognition and relationship to neurological abnormalities in Cockayne’s syndrome. Archives of Neurology, 35, 337-345. http://dx.doi.org/10.1001/archneur.1978.00500300011002
|
[11]
|
Broughton, B.C., Cordonnier, A., Kleijer, W.J., et al. (2002) Molecular analysis of mutations in DNA polymerase ETA in xeroderma pigmentosum-variant patients. Proceedings of the National Academy of Sciences of the United States of America, 99, 815-820. http://dx.doi.org/10.1073/pnas.022473899
|
[12]
|
Robbins, J.H., Kraemer, K.H., Merchant, S.N. and Brumback, R.A. (2002) Adult-onset xeroderma pigmentosum neurological disease—Observations in an autopsy case. Clinical Neuropathology, 21, 18-23.
|
[13]
|
Chidzonga, M.M., Mahomva, L., Makunike-Mutasa, R. and Masanganise, R. (2009) Xeroderma pigmentosum: A retrospective case series in Zimbabwe. Journal of Oral and Maxillofacial Surgery, 67, 22-31. http://dx.doi.org/10.1016/j.joms.2007.09.026
|
[14]
|
El Hefnawi, H., Rasheed, A. and Xeroderma, P. (1966) A report of further six cases. The Journal of the Egyptian Medical Association, 49, 419-434.
|
[15]
|
Blanksma, L.J., Donders, P.C. and van Voorst, V.P.C. (1986) Xeroderma pigmentosum and keratoconus. Documenta Ophthalmologica, 64, 97-103. http://dx.doi.org/10.1007/BF00166690
|
[16]
|
Johnson, M.W., Skuta, G.L., Kincaid, M.C., et al. (1989) Malignant melanoma of the iris in xeroderma pigmentosum. Archives of Ophthalmology, 107, 402-407. http://dx.doi.org/10.1001/archopht.1989.01070010412036
|
[17]
|
Kitagawa, K.O.T. and Inoue, M. (1981) Choroidal malignant melanoma occurring in a patient with xeroderma pigmentosum. Folia Ophthalmol Jpn, 32, 657-663.
|
[18]
|
Kraemer, K.H., DiGiovanna, J.J., Moshell, A.N., et al. (1988) Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. The New England Journal of Medicine, 318, 1633-1637. http://dx.doi.org/10.1056/NEJM198806233182501
|
[19]
|
Cook, Jr., B.E., and Bartley, G.B. (2001) Treatment options and future prospects for the management of eyelid malignancies: An evidence-based update. Ophthalmology, 108, 2088-2098. http://dx.doi.org/10.1016/S0161-6420(01)00796-5
|
[20]
|
Kearsley, J.H., Fitchew, R.S. and Taylor, R.G. (1988) Adjunctive radiotherapy with strontium-90 in the treatment of conjunctival squamous cell carcinoma. International Journal of Radiation Oncology, Biology, Physics, 14, 435-443. http://dx.doi.org/10.1016/0360-3016(88)90257-X
|
[21]
|
Shields, C.L. and Shields, J.A. (2004) Tumors of the conjunctiva and cornea. Survey of Ophthalmology, 49, 3-24. http://dx.doi.org/10.1016/j.survophthal.2003.10.008
|
[22]
|
Shields J. (2008) Melanocytic tumors of the iris stroma: Intraocular tumors: Atlas and textbook. 2nd Edition, Chapter 2, Lippincott Williams & Wilkins, Philadelphia, 22.
|
[23]
|
Limawararut, V., Leibovitch, I., Sullivan, T. and Selva, D. (2007) Periocular squamous cell carcinoma. Clinical & Experimental Ophthalmology, 35, 174-185. http://dx.doi.org/10.1111/j.1442-9071.2006.01411.x
|
[24]
|
DiGiovanna, J.J., Patronas, N., Katz, D., et al. (1998) Xeroderma pigmentosum: Spinal cord astrocytoma with 9-year survival after radiation and isotretinoin therapy. Journal of Cutaneous Medicine and Surgery, 2, 153-158.
|